Table 2.
Data related to ileostomy closure.
| Group A | Group B | p value | |
|---|---|---|---|
| (n = 115), (%) | (n = 100), (%) | ||
| Interval to ileostomy closure (day; IQR) | 98 (83–110) | 179 (152–211) | <0.001∗ |
| Operation time (min) | 87.41 ± 34.29 | 91.21 ± 37.99 | 0.442 |
| Blooding loss (mL) | 23.77 ± 16.72 | 25.15 ± 17.89 | 0.558 |
| Time to first flatus (day) | 3.28 ± 1.08 | 3.22 ± 0.92 | 0.673 |
| Time to fully oral nutrition (day) | 3.30 ± 1.08 | 3.32 ± 1.13 | 0.872 |
| Hospital stay (day) | 5.17 ± 1.87 | 5.31 ± 1.68 | 0.558 |
| Postoperative complications | 18/115 (15.7%) | 22/100 (22.0%) | 0.102 |
| Clavien–Dindo classification | |||
| Grade I | 8 (7.0%) | 8 (8.0%) | |
| Grade II | 2 (1.7%) | 10 (10.0%) | |
| Grade IIIa | 2 (1.7%) | 1 (1.0%) | |
| Grade IIIb | 6 (5.2%) | 3 (3.0%) | |
| Chemotherapy regimens | 0.686 | ||
| Monotherapy | 22 | 17 | |
| Combined chemotherapy | 93 | 83 | |
| Postoperative infection | 2 (1.7%) | 4 (4.0%) | 0.315 |
| Cost (yuan) | 39613.28 ± 11004.39 | 37142.76 ± 12427.55 | 0.124 |
| Increased creatinine (μmol/L) | 8.43 ± 31.26 | 4.95 ± 14.73 | 0.309 |
| Decreased BMI (kg/m2) | 0.91 ± 1.71 | 0.67 ± 1.46 | 0.275 |
| Anastomotic evaluation method | |||
| Endoscope | 99 (86.1%) | 91 (91.0%) | 0.262 |
| Endoscope + CT | 74 (64.3%) | 69 (69.0%) | 0.471 |
| Rectal anastomosis stenosis | 14 (12.2%) | 23 (23.0%) | 0.036∗ |
| Disused colitis | 29 (25.2%) | 25 (25%) | 0.971 |
| Chemotherapy cycles (times) | 5.19 ± 1.53 | 5.72 ± 1.41 | 0.009∗ |
| Follow-up time (IQR) | 36 (28–47) | 36 (29–51) | 0.393 |
| Postoperative regular follow-up | 78 (67.8%) | 66 (66.0%) | 0.726 |
IQR, interquartile range; BMI, body mass index; CT, computed tomography; ∗p < 0.05.